Intellectual Property Law Commons^™

A Fake Right Of Priority Under The Cross-Strait Agreement On Intellectual Property Right Protection And Cooperation, Ping-Hsun Chen Jan 2016

Table Of Content Jan 2015

Copyrights Without Limits—The Undefeatable Right Of Access Control Under §1201(A) Of The Digital Millennium Copyright Act, Kristian D. Stout Esq. Jan 2015

The Emerging Right To Communal Intellectual Property, Enninya S. Nwauche Jan 2015

Mylan V. Warner Chilcott: A Study In Pharmaceutical Product Hopping, Vikram Iyengar Jan 2015

Now Is That What I Call Music?: Post-Modern Classical Music And Copyright Law, Jamie M. Yu Jan 2015

Public K-12 Teachers Creation Of Nontraditional Educational Works: To Rely On The Teacher Exception Or Explore Other Options?, Katheryn Mills Jan 2015

Hart-Scott-Rodino & Chevron Step Zero: Can The Ftc Target The Pharmaceutical Industry?, Tyler Leverington Jan 2015

The Eu Trademark Reform Package—(Too) Bold A Step Ahead Or Back To Status Quo?, Annette Kur Jan 2015

The Intensifying National Interest In Patent Litigation, Kathleen M. O'Malley Jan 2015

Brands, Morality And Public Policy: Some Reflections On The Ban On Registration Of Controversial Trademarks, Enrico Bonadio Jan 2015

A Presidential Remedy Under Administrative Control—Why Section 337(J) Should Be Repealed, Nicolaas T. Bressers Jan 2015

Notice And Supplemental Registration: Why The Copyright Office Must Update Its Policies Surrounding Author Notice, Erin E. Kaprelian Jan 2015

The End Of The "Wild West" For Software Patents—Does The Patents Act 2013 Change New Zealand's Treatment Of Software Patents From Permissive To Restrictive?, Erin E. Block Jan 2015

Can The Pto Find Its Way With Jesus?, Lee B. Burgunder Jan 2015

Table Of Contents Jan 2015

Product Hopping 2.0: Getting The Fda To Yank Your Original License Beats Stacking Patents, Lars Noah Jan 2015

The New Era Of Biologic Regulation And Patenting Under The America Invents Act, David I. Rucker Jan 2014

Repurposing - Finding New Uses For Old (And Patented) Drugs: Bridging The "Valley Of Death," To Translate Academic Research Into New Medicines, Daniel S. Sem Jan 2014

Ip Policy Forum: Foreword From The Editors Jan 2014

A New Framework For Assessing Clinical Data Transparency Initiatives, Erika Lietzan Jan 2014

Diagnostic Patents At The Supreme Court, Arti K. Rai Jan 2014

Trademarks Under The North American Free Trade Agreement (Nafta), With References To The Current Mexican Law, Roberto Rosas Jan 2014

Territoriality Challenges In Protecting Trademark Interests In The System Of Generic Top-Level Domains (Gtlds), Jesse Kim Jan 2014

How Media Got The Biggest Bite Of (The) Apple: A Look At The Media Misperception In The Apple-Samsung Case, Neha Pathak Jan 2014

Ip Policy Forum: Drug Development - Translating Basic Research Into New Medicines - And This Issue Of Iplr, Tommy Thompson Jan 2014

Ip Policy Forum: Forward-Looking View Of Healthcare Innovation, From A Leading Life Science Venture Capitalist, G. Steven Burrill Jan 2014

Ip Policy Forum: The Increasing Importance Of Biologics-Based Drugs In Pharmaceutical Pipelines, David Meininger Jan 2014

Ip Policy Forum: Need For New Ip Approaches To Facilitate Collaborative (Academic-Industrial) Drug Development, Garret A. Fitzgerald Jan 2014

Ip Policy Forum: New Business Models To Find Cures And Lower Healthcare Costs: A Role For Drug Repurposing, Bruce Bloom Jan 2014